This suggests that both canonical (RelA, p50) and the noncanonical (e.g., RelB, p52) NF-κB subunits can be activated in prostate cancer cells, whereas c-Rel remains inactive. The gene discussed is NFKB2; the disease is Familial prostate cancer.